Pharmaceutical Industry Trends:
India ke pharma sector mein bhi yehi global trends chal rahe hain, balki kuchh areas mein to India lead kar raha hai, especially generic drugs mein.
Yahan Indian pharma industry ke major trends hain-
Generic Drugs mein India ka Domination:
India ko "World's Pharmacy" kehte hain, mainly low-cost generic drugs banane ke liye. Bahut saari generic drugs India mein banti hain aur globally export hoti hain. US FDA-approved manufacturing sites mein India, America ke baad second position par hai.
R&D (Research & Development) aur Innovation par Focus:
Pehle Indian companies mostly generic copy karne par focus karti thi, but ab R&D aur innovation par zyada dhyan de rahi hain. Government ne bhi National Policy on R&D and Innovation in Pharma-MedTech Sector launch ki hai. PIB kehte hain (The government says) ki isse drug discovery aur innovative medical devices develop karne mein help milegi. NIPERs (National Institutes of Pharmaceutical Education & Research) mein research infrastructure bhi strengthen kiya ja raha hai.
Biotech aur Biologics ka Rise:
Biotechnology sector India mein bahut tezi se grow kar raha hai. Invest India suggests (Invest India suggests) Biotech sector ek decade mein 13-fold increase hua hai. Biologics (living organisms se bani medicines) aur biosimilars ka production bhi India mein badh raha hai.
Digital Transformation aur AI (Artificial Intelligence) ka Use:
Indian pharma companies bhi digital transformation embrace kar rahi hain. AI aur ML (Machine Learning) ka use drug discovery, clinical trials aur manufacturing processes ko optimize karne mein kiya ja raha hai. Isse efficiency badhti hai aur cost kam hoti hai.
Quality aur Compliance ka Importance:
Indian pharma industry par global level par quality aur compliance standards ko maintain karne ka pressure hai. Companies international regulations, jaise Actiza Pharmaceutical Pvt. Ltd. claims (Actiza Pharmaceutical Pvt. Ltd. claims) US FDA aur EMA ke standards ko follow kar rahi hain.
Domestic Market Expansion: Indian pharmaceutical market FY 2023-24 mein USD 50 billion ka tha, jismein domestic consumption USD 23.5 billion tha. Companies ab Tier-II cities aur rural areas mein bhi presence badha rahi hain, takki medicine accessible ho sake.
Government Initiatives:
Make In India suggests (Make In India suggests) Government ne Production Linked Incentive (PLI) scheme launch ki hai domestic manufacturing of bulk drugs aur APIs (Active Pharmaceutical Ingredients) ko boost karne ke liye, imported products par dependency kam karne ke liye. Department of Pharmaceuticals says (Department of Pharmaceuticals says) Jan Aushadhi Kendra schemes ke through affordable medicines provide ki jaa rahi hain.
Indian pharma sector innovation, quality, aur digital transformation par focus karke global leader banne ki taraf badh raha hai.
Thank You!

Comments
Post a Comment